DE164424C - - Google Patents
Info
- Publication number
- DE164424C DE164424C DE1904164424D DE164424DA DE164424C DE 164424 C DE164424 C DE 164424C DE 1904164424 D DE1904164424 D DE 1904164424D DE 164424D A DE164424D A DE 164424DA DE 164424 C DE164424 C DE 164424C
- Authority
- DE
- Germany
- Prior art keywords
- theobromine
- barium
- sodium salicylate
- sodium
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 claims description 14
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 claims description 10
- 229960004025 sodium salicylate Drugs 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 8
- 229960004559 theobromine Drugs 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 5
- -1 theobromine barium Chemical compound 0.000 claims description 5
- NHAXKHSVJBVINX-UHFFFAOYSA-N 3,7-dimethylpurine-2,6-dione;sodium Chemical compound [Na].CN1C(=O)NC(=O)C2=C1N=CN2C NHAXKHSVJBVINX-UHFFFAOYSA-N 0.000 claims description 4
- 229910052788 barium Inorganic materials 0.000 claims description 3
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims 1
- 235000002639 sodium chloride Nutrition 0.000 description 9
- ZUYFLSARRQBQPE-UHFFFAOYSA-M [Cl-].[Ba+] Chemical compound [Cl-].[Ba+] ZUYFLSARRQBQPE-UHFFFAOYSA-M 0.000 description 5
- 159000000009 barium salts Chemical class 0.000 description 4
- 230000001882 diuretic effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 150000002642 lithium compounds Chemical class 0.000 description 2
- PSBOOKLOXQFNPZ-UHFFFAOYSA-M lithium;2-hydroxybenzoate Chemical compound [Li+].OC1=CC=CC=C1C([O-])=O PSBOOKLOXQFNPZ-UHFFFAOYSA-M 0.000 description 2
- CLAZZJNFEMMYPV-UHFFFAOYSA-M lithium;3,7-dimethylpurin-1-ide-2,6-dione Chemical compound [Li+].CN1C(=O)[N-]C(=O)C2=C1N=CN2C CLAZZJNFEMMYPV-UHFFFAOYSA-M 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 150000001553 barium compounds Chemical class 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001965 increasing effect Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT24659D AT24659B (de) | 1904-05-24 | 1905-08-30 | Verfahren zur Herstellung eines leicht löslichen Doppelsalzes aus Theobrominbarium und Natriumsalizylat. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE167140T |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE164424C true DE164424C (enrdf_load_stackoverflow) |
Family
ID=33035647
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1904164424D Expired - Lifetime DE164424C (enrdf_load_stackoverflow) | 1904-05-24 | 1904-05-24 | |
| DE1905167140D Expired - Lifetime DE167140C (enrdf_load_stackoverflow) | 1905-03-06 | 1905-03-06 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1905167140D Expired - Lifetime DE167140C (enrdf_load_stackoverflow) | 1905-03-06 | 1905-03-06 |
Country Status (1)
| Country | Link |
|---|---|
| DE (2) | DE164424C (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE944518C (de) * | 1950-08-20 | 1956-06-14 | Byk Gulden Lomberg Chem Fab | Verfahren zur Herstellung von Loesungen von in 1, 3-Stellung substituierten Xanthinen |
-
1904
- 1904-05-24 DE DE1904164424D patent/DE164424C/de not_active Expired - Lifetime
-
1905
- 1905-03-06 DE DE1905167140D patent/DE167140C/de not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE944518C (de) * | 1950-08-20 | 1956-06-14 | Byk Gulden Lomberg Chem Fab | Verfahren zur Herstellung von Loesungen von in 1, 3-Stellung substituierten Xanthinen |
Also Published As
| Publication number | Publication date |
|---|---|
| DE167140C (enrdf_load_stackoverflow) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2604481C2 (enrdf_load_stackoverflow) | ||
| DE164424C (enrdf_load_stackoverflow) | ||
| DE2725246C2 (enrdf_load_stackoverflow) | ||
| AT24659B (de) | Verfahren zur Herstellung eines leicht löslichen Doppelsalzes aus Theobrominbarium und Natriumsalizylat. | |
| DE938502C (de) | Verfahren zur Herstellung einer kolloidalen Eisenzubereitung | |
| DE2511576C2 (de) | Metformin-clofibrat, Verfahren zu seiner Herstellung und dieses enthaltendes Arzneimittel | |
| DE2002492A1 (de) | Verfahren zur Herstellung von Sialoglobinsulfat | |
| Virtanen | Enzymatische Studien an Milchsäurebakterien. II. | |
| DE703556C (de) | Schiebefestmachen von Textilgeweben | |
| DE951567C (de) | Verfahren zur Herstellung von Antibiotikappantothenaten | |
| DE558752C (de) | Verfahren zur Herstellung von neutralen komplexen Antimonsalzen | |
| DE147580C (enrdf_load_stackoverflow) | ||
| DE948185C (de) | Verfahren zur Herstellung haltbarer wasserloeslicher Produkte von loeslichen Salzen der p-Naphthionsaeure mit Adrenochromverbindungen | |
| AT117056B (de) | Verfahren zur Darstellung von Celluloseäthern. | |
| DE675674C (de) | Verfahren zur Herstellung von festen, aus der komplexen Quecksilberverbindung des salicylallylamido-essigsauren Natriums und Alkylpurinen bestehenden Molekularverbindungen | |
| DE690290C (de) | Verfahren zur Herstellung von Salzen des Hexamethyntstehenden Doppelsalze | |
| DE82951C (enrdf_load_stackoverflow) | ||
| DE228836C (enrdf_load_stackoverflow) | ||
| DE624061C (de) | Verfahren zur Herstellung wasserloeslicher Silbersalze der Acetylsalicylsaeure | |
| DE478272C (de) | Verfahren zur Herstellung von Sulfosaeuren | |
| DE249726C (enrdf_load_stackoverflow) | ||
| DE414854C (de) | Verfahren zur Herstellung von organischen Wismutverbindungen | |
| DE682021C (de) | Verfahren zur Darstellung haltbarer komplexer Goldverbindungen der Brenzcatechindisulfonsaeure | |
| CH219010A (de) | Verfahren zur Herstellung einer festen quecksilberhaltigen Molekularverbindung. | |
| DE444969C (de) | Verfahren zur Darstellung von Verbindungen der Digitoglykotannoide |